KI Pill Working Group: Draft Report

Consultation on the Potassium Iodide (KI) Pill Working Group's draft report on the Emergency Distribution of Potassium Iodide Within the Ingestion Planning Zone (IPZ) of Pickering Nuclear Generating Station is open from April 6 to July 5, 2021.

In 2019, the CNSC established the KI Pill Working Group to provide clarity on the existing plans and associated responsible authorities to distribute KI pills int he IPZ, in the event of an emergency at the Pickering Nuclear Generating Station.

This draft report was written to meet the mandate of Phase I of the Working Group:

“To fulfill the commitment to the Commission to provide clarity on the existing plans and associated responsible authorities for distributing Potassium Iodide (KI) pills in the ingestion planning zone in the event of an emergency at the Pickering Nuclear Generating Station.”

How to Participate:

The CNSC invites you to comment on the draft report produced by the KI Pill Working Group. The CNSC would also like to hear from you on how well this draft report meets the mandate of Phase I of the Working Group.

The opportunity for reviewers to provide feedback on this draft report is part of the CNSC’s commitment to a transparent consultation process.

For general inquiries, please contact us at cnsc.info.ccsn@canada.ca.

For all media inquiries, please contact us at cnsc.mediarelations-relationsmedias.ccsn@canada.ca.

Consultation on the Potassium Iodide (KI) Pill Working Group's draft report on the Emergency Distribution of Potassium Iodide Within the Ingestion Planning Zone (IPZ) of Pickering Nuclear Generating Station is open from April 6 to July 5, 2021.

In 2019, the CNSC established the KI Pill Working Group to provide clarity on the existing plans and associated responsible authorities to distribute KI pills int he IPZ, in the event of an emergency at the Pickering Nuclear Generating Station.

This draft report was written to meet the mandate of Phase I of the Working Group:

“To fulfill the commitment to the Commission to provide clarity on the existing plans and associated responsible authorities for distributing Potassium Iodide (KI) pills in the ingestion planning zone in the event of an emergency at the Pickering Nuclear Generating Station.”

How to Participate:

The CNSC invites you to comment on the draft report produced by the KI Pill Working Group. The CNSC would also like to hear from you on how well this draft report meets the mandate of Phase I of the Working Group.

The opportunity for reviewers to provide feedback on this draft report is part of the CNSC’s commitment to a transparent consultation process.

For general inquiries, please contact us at cnsc.info.ccsn@canada.ca.

For all media inquiries, please contact us at cnsc.mediarelations-relationsmedias.ccsn@canada.ca.

Additional questions about the KI Pill Working Group Draft Report.

Can I submit my comments by email?

If you prefer to submit comments by email, please send your comments to cnsc.consultation.ccsn@canada.ca.


Please submit any additional questions you may have on the status or content of the KI Pill Working Group Draft Report.

loader image
Didn't receive confirmation?
Seems like you are already registered, please provide the password. Forgot your password? Create a new one now.